Cyclooxygenase 2 Inhibitors [clinicaltrials_resource:d2e95418ecffcc97040b570f0eb12098]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00046839Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women [clinicaltrials:NCT00056082]clinicaltrials:NCT00104767COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis [clinicaltrials:NCT00113308]Celebrex - Cervix [clinicaltrials:NCT00152828]clinicaltrials:NCT00314262clinicaltrials:NCT00400374Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia [clinicaltrials:NCT00442676]Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway [clinicaltrials:NCT00498134]Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery [clinicaltrials:NCT00502684]clinicaltrials:NCT00510822clinicaltrials:NCT00581971COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma [clinicaltrials:NCT00603759]A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction [clinicaltrials:NCT00663767]β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence [clinicaltrials:NCT00888797]clinicaltrials:NCT01111591clinicaltrials:NCT01129245Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients [clinicaltrials:NCT01269515]Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082) [clinicaltrials:NCT01327638]clinicaltrials:NCT01346137COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined [clinicaltrials:NCT01361789]clinicaltrials:NCT01479829clinicaltrials:NCT01678313Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women [clinicaltrials:NCT01839643]TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial [clinicaltrials:NCT02060006]EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT). [clinicaltrials:NCT02149758]Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy [clinicaltrials:NCT02438709]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Cyclooxygenase 2 Inhibitors [clinicaltrials_resource:d2e95418ecffcc97040b570f0eb12098]
Bio2RDF identifier
d2e95418ecffcc97040b570f0eb12098
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d2e95418ecffcc97040b570f0eb12098
identifier
clinicaltrials_resource:d2e95418ecffcc97040b570f0eb12098
title
Cyclooxygenase 2 Inhibitors
@en
type
label
Cyclooxygenase 2 Inhibitors [clinicaltrials_resource:d2e95418ecffcc97040b570f0eb12098]
@en